Antibodies 2013, 2(2), 236-269; doi:10.3390/antib2020236
Review

Ricin and Ricin-Containing Immunotoxins: Insights into Intracellular Transport and Mechanism of action in Vitro

1 Department of Molecular Biology, University of Gdańsk, Wita Stwosza 59, 80-308 Gdańsk, Poland 2 Department of Biochemistry, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310 Oslo, Norway 3 Centre for Cancer Biomedicine, University of Oslo, Montebello, N-0310 Oslo, Norway
* Author to whom correspondence should be addressed.
Received: 27 December 2012; in revised form: 8 April 2013 / Accepted: 11 April 2013 / Published: 19 April 2013
(This article belongs to the Special Issue Recombinant Immunotoxins)
PDF Full-text Download PDF Full-Text [337 KB, uploaded 19 April 2013 15:30 CEST]
Abstract: Ricin is a type II ribosome inactivating protein (RIP) isolated from castor beans. Its high toxicity classifies it as a possible biological weapon. On the other hand, ricin linked to specific monoclonal antibodies or used in other conjugates has powerful medical applications. Ricin consists of an A-chain (RTA) that damages ribosomes and inhibits protein synthesis, and a B-chain that plays a role in binding and cellular uptake. A number of recent studies have demonstrated that ricin-induced inhibition of protein synthesis is not the only mechanism responsible for cell death. It turns out that ricin is able to induce apoptosis in different cell lines and multiple organs in animals. However, the molecular link between protein synthesis inhibition and ricin-dependent triggering of apoptotic cell death is unclear. This review describes the intracellular transport of ricin and ricin-based immunotoxins and their mechanism of action in different non-malignant and cancer cell lines. Moreover, various ricin-containing immunotoxins, their composition, medical applications and side-effects will be described and discussed. Understanding the mechanism of action of ricin-based immunotoxins will facilitate construction of effectively acting immunotoxins that can be used in the clinic for cancer treatment.
Keywords: ricin; ricin-based immunotoxins; intracellular transport; apoptosis; vascular leak syndrome

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Słomińska-Wojewódzka, M.; Sandvig, K. Ricin and Ricin-Containing Immunotoxins: Insights into Intracellular Transport and Mechanism of action in Vitro. Antibodies 2013, 2, 236-269.

AMA Style

Słomińska-Wojewódzka M, Sandvig K. Ricin and Ricin-Containing Immunotoxins: Insights into Intracellular Transport and Mechanism of action in Vitro. Antibodies. 2013; 2(2):236-269.

Chicago/Turabian Style

Słomińska-Wojewódzka, Monika; Sandvig, Kirsten. 2013. "Ricin and Ricin-Containing Immunotoxins: Insights into Intracellular Transport and Mechanism of action in Vitro." Antibodies 2, no. 2: 236-269.

Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert